Clinical Trial Update: A Study of CellCept (Mycophenolate Mofetil) in Combination Therapy in Liver Transplant Patients. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating CellCept (mycophenolate mofetil) in combination therapy for liver transplant patients has completed, with results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplantation

Drugs mentioned

• CELLCEPT (mycophenolate mofetil hydrochloride)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Liver Transplantation | Phase 4 | Status: COMPLETED | Results posted: 2014-07-14